Pain Felt During Removal of the Products From Infant's Skin Used in Nasogastric Tube Fixation

Sponsor
Marmara University (Other)
Overall Status
Completed
CT.gov ID
NCT05064072
Collaborator
(none)
120
1
3
2.5
48.1

Study Details

Study Description

Brief Summary

The present study was planned to evaluate the pain of 4-6 weeks infants felt during removal of the adhesive products from newborn's skin used in the fixation of nasogastric tube in neonatal and infant units. The hypothesis of the study is "Water-based barrier tape is more effective to reduce pain than hydrocolloid barrier tape.

Condition or Disease Intervention/Treatment Phase
  • Device: Water-based barrier tape
  • Device: Hydrocolloid barrier tape
  • Device: Silk tape
N/A

Detailed Description

The study was planned as randomized controlled and experimental design to compare the efficiency of three different methods reducing pain during removal adhesive products for 4-6 weeks infants. The universe of the study consisted of 4-6 weeks infants in neonatal and infants clinics of Giresun Women's and Children's Hospital between the dates of July-September 2021. Power analysis was performed through G*Power (v3.1.7) programme in order to determine the number of the sample. At the beginning of the study, a reference study (Kemer, 2020) was used for sample calculation. The effect size was calculated as d=0.561 regarding the assessment of skin condition scores and 120 participants in total should be included in the study as 40 participants for each groups in order to obtain 80% power in the level of α=0.05. Block randomization technique is applied in the study as a randomization method. "As for data collection "Infant description form" and "Neonatal Infant Pain Scale" was used. The scale was filled by two independent observer via double-blind method.

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Evaluation of Pain Felt During Removal of the Products From Infant's Skin Used in Nasogastric Tube Fixation: Randomized Controlled Study
Actual Study Start Date :
Jul 1, 2021
Actual Primary Completion Date :
Sep 15, 2021
Actual Study Completion Date :
Sep 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Water-based barrier tape

The infants in experiment 1 group will be applied water-based barrier tape will be used to fix the nasogastric tube

Device: Water-based barrier tape
The infants in experiment 1 group will be applied water-based barrier tape. The area will be covered by water-based barrier tape to fix nasogastric tube and after waiting 1 minute for drying up it will be fastened by silk tape used in clinic. The silk tape will be 5 cm long and it will be changed in every 24 hours. Following the removal of silk tape on the water-based barrier tape, the pain felt by the infants evaluated through "Neonatal Infant Pain Scale" and the score recorded in the chart. This procedure actualized 3 min. before procedure, during and 3 min after procedure.

Experimental: Hydrocolloid barrier tape

The infants in experiment 2 group, hydrocolloid barrier tape will be used to fix the nasogastric tube

Device: Hydrocolloid barrier tape
As for experiment 2 group, hydrocolloid barrier tape will be used to fix the nasogastric tube. The hydrocolloid barrier tape, which was cut and shaped appropriately beforehand, will be applied to the area in order to stabilize the nasogastric tube and the tube will be stabilized with silk tape used in clinic. The silk tape will be 5 cm long and it will be changed in every 24 hours. Following the removal of silk tape on the hydrocolloid barrier tape, the pain felt by the infants evaluated with "Neonatal Infant Pain Scale" and the score recorded in the chart. Since the hydrocolloid barrier tape can stay on the skin for 7 days and the assessment of the pain realized in 7th day and noted down to the chart. Pain score evaluated in 7th day 3 min. before procedure, during and 3 min after procedure

Active Comparator: Silk plaster

The silk plaster used in clinic routinely will be used for control group infants to fix the nasogastric tube

Device: Silk tape
The silk tape used in clinic routinely will be used for control group infants to fix the nasogastric tube without any barrier. The silk tape will be 5cm long and it will be changed in every 24 hours. Following the removal of silk tape on the silk tape, the pain felt by the infants evaluated through "Neonatal Infant Pain Scale" and the score recorded in the chart. This procedure actualized 3 min. before procedure, during and 3 min after procedure

Outcome Measures

Primary Outcome Measures

  1. Water-based barrier tape [24 hours]

    To evaluate pain felt by infants following the removal of silk adhesive from water-based barrier tape

  2. Hydrocolloid barrier tape [24 hours]

    To evaluate pain felt by infants following the removal of silk adhesive from hydrocolloid barrier tape

  3. Silk Tape [24 hours]

    To evaluate pain felt by infants following the removal of silk adhesive from infants skin without any barrier tape

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Weeks to 6 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All the 4-6 weeks infants including interventional process and without any skin diseases
Exclusion Criteria:
  • The infants receiving treatment without any interventional process

  • Those having a skin disease

  • Those infants having peripherally inserted central venous catheter

Contacts and Locations

Locations

Site City State Country Postal Code
1 Giresun University Women and Children's Hospital Giresun Turkey

Sponsors and Collaborators

  • Marmara University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marmara University
ClinicalTrials.gov Identifier:
NCT05064072
Other Study ID Numbers:
  • 23618724
First Posted:
Oct 1, 2021
Last Update Posted:
Oct 1, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marmara University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 1, 2021